News-Medical.Net raptiva News Feed

Channel: News-Medical.Net raptiva News Feed

↧

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

July 26, 2006, 1:16 am

NICE has today issued guidance for the use of the targeted biological therapies, Enbrel (etanercept) and Raptiva (efalizumab), to treat adult patients with severe plaque psoriasis.

View Article

Efalizumab effective in treatment of heavy psoriasis

August 3, 2007, 9:05 am

A meta-analysis of four randomized Phase III placebo-controlled trials confirms that the injectable drug Efalizumab, a humanized therapeutic antibody designed to selectively and reversibly block the...

View Article

FDA approves new labeling for psoriasis drug Raptiva

October 19, 2008, 3:25 pm

The U.S. Food and Drug Administration today announced labeling changes, including a Boxed Warning, to highlight the risks of life-threatening infections, including progressive multifocal...

View Article

FDA issues warning on psoriasis drug Raptiva (efalizumab)

February 20, 2009, 7:50 am

The U.S. Food and Drug Administration has issued a public health advisory concerning three confirmed, and one possible report of progressive multifocal leukoencephalopathy (PML), a rare brain...

View Article

CytoDyn responds to FDA as high court rules agency cannot guarantee drug safety

March 10, 2009, 10:30 am

CytoDyn, Inc. has sent the FDA what the Company believes is a complete response to the agency's preliminary comments on Cytolin, a monoclonal antibody designed to restore immune function in those...

View Article

Withdrawal of Raptiva from U.S. market

April 8, 2009, 5:23 pm

Genentech, the manufacturer of the psoriasis drug Raptiva (efalizumab), has announced that it has begun a voluntary, phased withdrawal of the product from the U.S. market.

View Article

Rituximab linked to viral brain infection

May 18, 2009, 1:40 pm

The 57-year-old lawyer in New York had handily completed the New York Times' Saturday crossword puzzle - the hardest of the week - for years. But one Saturday morning, suddenly he couldn't retrieve the...

View Article

Dermatologists express strong interest in Stelara, despite concerns

November 25, 2009, 8:09 pm

BioTrends Research Group, Inc. released Wave 1 of its LaunchTrends(TM): Stelara report, the first in a multi-phase syndicated market research project tracking the launch of Centocor Ortho-Biotech's...

View Article

BioTrends' Stelara second wave report finds increase in prescribing among...

February 19, 2010, 2:18 am

BioTrends published the second wave of LaunchTrends®: Stelara, highlighting dermatology market trends at three months post launch. The report is based on 76 survey responses and 20 qualitative phone...

View Article

Leukothera effectively treats psoriasis in humanized mouse xenograft...

June 15, 2011, 4:39 am

Psoriasis is a persistent, long-lasting chronic skin disease affecting 2-3 percent of the world's population or more than 125 million individuals. For some, it is just a nuisance. For others, it is...

View Article